ExxonMobil Signals Q3 Earnings Decline, Reinforcing Cautious Stance

What happened

ExxonMobil has signaled that third-quarter 2026 earnings will be lower, consistent with the retreat in oil prices and refining margins from peak levels seen earlier in the year. This development aligns with the latest DeepValue report, which rated the stock a Potential Sell at $157 on conviction that commodity normalization would outpace advantaged volume growth. The company’s second-quarter earnings had been inflated by a one-time uplift in liquids prices and energy products margins, a benefit that was never expected to persist. With EIA forecasting Brent to average $65/bbl in 2027 and refining spreads narrowing, the third-quarter signal confirms that earnings are resetting toward a lower run-rate. The market’s prior narrative of tight inventories and windfall profits is giving way to a more sober assessment of Exxon’s dependence on external pricing, and the stock’s valuation at over 26x earnings leaves little room for disappointment.

Implication

The Q3 earnings signal supports the Potential Sell rating by validating the report’s core concern: that Exxon’s recent earnings strength was driven by temporarily elevated commodity prices and refining margins rather than a durable improvement in normalized earnings power. With the company now flagging lower third-quarter results, the market must reprice the stock away from peak cyclical earnings, likely toward the base-case implied value of $155 or below. Investors should reduce exposure if the stock remains near the $157 level, as the risk/reward is skewed to the downside given the 26.6x earnings multiple and the EIA’s lower 2027 oil price forecast. The attractive entry point remains $142, where the margin of safety becomes more compelling, but only if Guyana’s Uaru project and Golden Pass LNG ramp stay on schedule. Over the next three to six months, monitor whether the company’s fourth-quarter guidance or project updates can offset the commodity headwinds; otherwise, further downside toward the bear-case $138 is plausible.

Thesis delta

The new information does not change the underlying thesis but reinforces the bearish lean by confirming that earnings are already rolling over from the Q2 peak. The prior call for a Potential Sell with trim above $170 and entry at $142 remains intact, but the Q3 signal increases the probability that the stock tests the lower end of the range before any recovery. The key watchpoint now shifts to whether Q4 guidance or Uaru/Golden Pass milestones can provide countervailing positive catalysts, otherwise the thesis may strengthen further.